Eledon Pharmaceuticals
ELDN
ELDN
19 hedge funds and large institutions have $16.1M invested in Eledon Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
79% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 19
Holders
19
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$14.8M | |
| 2 | +$238K | |
| 3 | +$145K | |
| 4 |
Renaissance Technologies
New York
|
+$100K |
| 5 |
Goldman Sachs
New York
|
+$65.7K |
Top Sellers
| 1 | -$238K | |
| 2 | -$115K | |
| 3 | -$89K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$87K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$70K |